Header Logo

Connection

DANIEL LEUNG to Cystic Fibrosis

Back to Details
This is a "connection" page, showing publications DANIEL LEUNG has written about Cystic Fibrosis.
DANIEL LEUNG
Connection Strength
8.594
Cystic Fibrosis
  1. Advanced cystic fibrosis liver disease: Endovascular, endoscopic, radiologic, and surgical considerations. Pediatr Pulmonol. 2024 Sep; 59 Suppl 1:S115-S122.
    View in: PubMed
    Score: 0.696
  2. Risk factors for more rapid progression of severe liver fibrosis in children with cystic fibrosis-related liver disease: A multi-center study validated by liver biopsy. Liver Int. 2023 06; 43(6):1277-1286.
    View in: PubMed
    Score: 0.632
  3. Long-term follow-up and liver outcomes in children with cystic fibrosis and nodular liver on ultrasound in a multi-center study. J Cyst Fibros. 2023 03; 22(2):248-255.
    View in: PubMed
    Score: 0.604
  4. The Emergence of Elastography for Cystic Fibrosis Liver Disease. J Cyst Fibros. 2020 05; 19(3):339-341.
    View in: PubMed
    Score: 0.515
  5. A Multidisciplinary Approach to Pretransplant and Posttransplant Management of Cystic Fibrosis-Associated Liver Disease. Liver Transpl. 2019 04; 25(4):640-657.
    View in: PubMed
    Score: 0.477
  6. Obliterative Portal Venopathy Without Cirrhosis Is Prevalent in Pediatric Cystic Fibrosis Liver Disease With Portal Hypertension. Clin Gastroenterol Hepatol. 2019 09; 17(10):2134-2136.
    View in: PubMed
    Score: 0.465
  7. Cystic Fibrosis-related cirrhosis. J Cyst Fibros. 2017 Nov; 16 Suppl 2:S50-S61.
    View in: PubMed
    Score: 0.434
  8. Effects of Diagnosis by Newborn Screening for Cystic Fibrosis on Weight and Length in the First Year of Life. JAMA Pediatr. 2017 06 01; 171(6):546-554.
    View in: PubMed
    Score: 0.421
  9. 50 Years Ago in TheJournal ofPediatrics: Macroscopic Cysts of the Pancreas in a Case of Cystic Fibrosis. J Pediatr. 2016 09; 176:133.
    View in: PubMed
    Score: 0.400
  10. Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease. Hepatology. 2015 Nov; 62(5):1576-83.
    View in: PubMed
    Score: 0.375
  11. Baseline Ultrasound and Clinical Correlates in Children with Cystic Fibrosis. J Pediatr. 2015 Oct; 167(4):862-868.e2.
    View in: PubMed
    Score: 0.371
  12. The Impact of Elexacaftor-Tezacaftor-Ivacaftor on Biochemical Surrogates of Cystic Fibrosis Hepatobiliary Involvement: A Retrospective Cohort Study. Pediatr Pulmonol. 2026 Feb; 61(2):e71522.
    View in: PubMed
    Score: 0.192
  13. Impact of elexacaftor/tezacaftor/ivacaftor on biomarkers of cystic fibrosis hepatobiliary involvement in the PUSH study. J Pediatr Gastroenterol Nutr. 2026 Feb; 82(2):350-357.
    View in: PubMed
    Score: 0.190
  14. Gastrointestinal Burden in Patients With Pancreatic Insufficient Cystic Fibrosis Before and After Elexacaftor/Tezacaftor/Ivacaftor Use. Pancreas. 2025 Nov-Dec 01; 54(10):e858-e862.
    View in: PubMed
    Score: 0.184
  15. SHIFTing goals in cystic fibrosis-managing extrapulmonary disease in the era of CFTR modulator therapy; Proceedings of the International Shaping Initiatives and Future Trends (SHIFT) Symposium. Pediatr Pulmonol. 2024 06; 59(6):1661-1676.
    View in: PubMed
    Score: 0.169
  16. Prospective study of quantitative liver MRI in cystic fibrosis: feasibility and comparison to PUSH cohort ultrasound. Pediatr Radiol. 2023 10; 53(11):2210-2220.
    View in: PubMed
    Score: 0.161
  17. Upper airway microbiota development in infants with cystic fibrosis diagnosed by newborn screen. J Cyst Fibros. 2023 07; 22(4):644-651.
    View in: PubMed
    Score: 0.159
  18. Heterogeneous liver on research ultrasound identifies children with cystic fibrosis at high risk of advanced liver disease. J Cyst Fibros. 2023 07; 22(4):745-755.
    View in: PubMed
    Score: 0.158
  19. Health-related Quality of Life in a Prospective Study of Ultrasound to Detect Cystic Fibrosis-related Liver Disease in Children. J Pediatr Gastroenterol Nutr. 2022 11 01; 75(5):635-642.
    View in: PubMed
    Score: 0.152
  20. Association between stool consistency and clinical variables among infants with cystic fibrosis: Findings from the BONUS study. J Cyst Fibros. 2022 09; 21(5):830-836.
    View in: PubMed
    Score: 0.148
  21. Gamma-glutamyl transpeptidase-to-platelet ratio as a biomarker of liver disease and hepatic fibrosis severity in paediatric Cystic Fibrosis. J Cyst Fibros. 2022 03; 21(2):236-242.
    View in: PubMed
    Score: 0.144
  22. Infants with cystic fibrosis have altered fecal functional capacities with potential clinical and metabolic consequences. BMC Microbiol. 2021 09 15; 21(1):247.
    View in: PubMed
    Score: 0.142
  23. Gastrointestinal Factors Associated With Hospitalization in Infants With Cystic Fibrosis: Results From the Baby Observational and Nutrition Study. J Pediatr Gastroenterol Nutr. 2021 09 01; 73(3):395-402.
    View in: PubMed
    Score: 0.141
  24. Heterogeneous Liver on Research Ultrasound Identifies Children with Cystic Fibrosis at High Risk of Advanced Liver Disease: Interim Results of a Prospective Observational Case-Controlled Study. J Pediatr. 2020 04; 219:62-69.e4.
    View in: PubMed
    Score: 0.127
  25. Fecal dysbiosis in infants with cystic fibrosis is associated with early linear growth failure. Nat Med. 2020 02; 26(2):215-221.
    View in: PubMed
    Score: 0.126
  26. Liver Ultrasound Patterns in Children With Cystic Fibrosis Correlate With Noninvasive Tests of Liver Disease. J Pediatr Gastroenterol Nutr. 2019 09; 69(3):351-357.
    View in: PubMed
    Score: 0.123
  27. Pulmonary findings in infants with cystic fibrosis during the first year of life: Results from the Baby Observational and Nutrition Study (BONUS) cohort study. Pediatr Pulmonol. 2019 05; 54(5):581-586.
    View in: PubMed
    Score: 0.118
  28. Hepatic Steatosis Is Prevalent Following Orthotopic Liver Transplantation in Children With Cystic Fibrosis. J Pediatr Gastroenterol Nutr. 2019 01; 68(1):96-103.
    View in: PubMed
    Score: 0.118
  29. MicroRNA Sequencing Identifies a Serum MicroRNA Panel, Which Combined With Aspartate Aminotransferase to Platelet Ratio Index Can Detect and Monitor Liver Disease in Pediatric Cystic Fibrosis. Hepatology. 2018 12; 68(6):2301-2316.
    View in: PubMed
    Score: 0.116
  30. Pancreatic Enzyme Replacement Therapy Use in Infants With Cystic Fibrosis Diagnosed by Newborn Screening. J Pediatr Gastroenterol Nutr. 2018 04; 66(4):657-663.
    View in: PubMed
    Score: 0.112
  31. Variceal Hemorrhage and Adverse Liver Outcomes in Patients With Cystic Fibrosis Cirrhosis. J Pediatr Gastroenterol Nutr. 2018 01; 66(1):122-127.
    View in: PubMed
    Score: 0.110
  32. The intestinal microbiome and paediatric liver disease. Lancet Gastroenterol Hepatol. 2017 06; 2(6):446-455.
    View in: PubMed
    Score: 0.105
  33. Standardization of Research-Quality Anthropometric Measurement of Infants and Implementation in a Multicenter Study. Clin Transl Sci. 2015 Aug; 8(4):330-3.
    View in: PubMed
    Score: 0.092
  34. Early attained weight and length predict growth faltering better than velocity measures in infants with CF. J Cyst Fibros. 2014 Dec; 13(6):723-9.
    View in: PubMed
    Score: 0.086
  35. Accuracy of Transient Elastography Data Combined With APRI in Detection and Staging of Liver Disease in Pediatric Patients With Cystic Fibrosis. Clin Gastroenterol Hepatol. 2019 11; 17(12):2561-2569.e5.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.